Literature DB >> 16892027

Targeted cancer therapeutics: the heartbreak of success.

Douglas L Mann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16892027     DOI: 10.1038/nm0806-881

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

Review 1.  Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Authors:  Steven E Lipshultz; Melissa B Diamond; Vivian I Franco; Sanjeev Aggarwal; Kasey Leger; Maria Verônica Santos; Stephen E Sallan; Eric J Chow
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

Review 2.  Chemotherapy and cardiotoxicity.

Authors:  Howard Broder; Roberta A Gottlieb; Norman E Lepor
Journal:  Rev Cardiovasc Med       Date:  2008       Impact factor: 2.930

3.  Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters.

Authors:  Shuiying Hu; Zhaoyuan Chen; Ryan Franke; Shelley Orwick; Ming Zhao; Michelle A Rudek; Alex Sparreboom; Sharyn D Baker
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

Review 4.  Cardiac toxicity: old and new issues in anti-cancer drugs.

Authors:  M Sereno; A Brunello; A Chiappori; J Barriuso; E Casado; C Belda; J de Castro; J Feliu; M González-Barón
Journal:  Clin Transl Oncol       Date:  2008-01       Impact factor: 3.405

Review 5.  Is the use of sentient animals in basic research justifiable?

Authors:  Ray Greek; Jean Greek
Journal:  Philos Ethics Humanit Med       Date:  2010-09-08       Impact factor: 2.464

Review 6.  Cardiac dysfunction induced by novel targeted anticancer therapy: an emerging issue.

Authors:  Ming Hui Chen
Journal:  Curr Cardiol Rep       Date:  2009-05       Impact factor: 2.931

7.  Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells.

Authors:  Neil L Spector; Yosef Yarden; Bradley Smith; Ljuba Lyass; Patricia Trusk; Karen Pry; Jason E Hill; Wenle Xia; Rony Seger; Sarah S Bacus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-07       Impact factor: 11.205

8.  Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.

Authors:  Tammy F Chu; Maria A Rupnick; Risto Kerkela; Susan M Dallabrida; David Zurakowski; Lisa Nguyen; Kathleen Woulfe; Elke Pravda; Flavia Cassiola; Jayesh Desai; Suzanne George; Jeffrey A Morgan; David M Harris; Nesreen S Ismail; Jey-Hsin Chen; Frederick J Schoen; Annick D Van den Abbeele; George D Demetri; Thomas Force; Ming Hui Chen
Journal:  Lancet       Date:  2007-12-15       Impact factor: 79.321

9.  The institutional review board is an impediment to human research: the result is more animal-based research.

Authors:  Mark J Rice
Journal:  Philos Ethics Humanit Med       Date:  2011-06-07       Impact factor: 2.464

10.  FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.

Authors:  BeeShin Tan; Matthew Anaka; Siddhartha Deb; Claudia Freyer; Lisa M Ebert; Anderly C Chueh; Sheren Al-Obaidi; Andreas Behren; Aparna Jayachandran; Jonathan Cebon; Weisan Chen; John M Mariadason
Journal:  Oncotarget       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.